Another study showed that CAR T-cells support HRG1β to successfully abolish breast cancer cell proliferation through HER family receptors and deliver a practical therapeutic approach to overcome cancer resistance, specifically against HER2-based targeted therapy (34). Here, ERBB2 is linked to breast carcinoma.